ISSAQUAH, WA, Jan. 23, 2013 - With spring sports starting, don't drop the ball on nutrition. Nutrition is just as important as physical conditioning for athletes. So, as spring sports begin, let Swedish help you and your children prepare to hit it out of the park. Join Registered Dietitian Ally Colson for an interactive training on game-winning meals and snacks and help your young athlete become a nutrition champion.
(Left to right) Leah Binder, president and CEO of The Leapfrog Group, presents the Top Hospital Award to Director of Quality and Patient Safety Mary Gregg, M.D., Chief Medical Officer John Vassall, M.D., and Quality and Patient Safety Data Analyst Mike Weidemann.
SEATTLE, Dec. 4, 2012 – The Leapfrog Group’s annual class of ‘Top Hospitals’ – just 89 from a field of nearly 1,200 – was announced today in Baltimore, Md., and includes Swedish Medical Center/First Hill for the third year in a row. The announcement took place at Leapfrog’s Annual Meeting.
SEATTLE, Nov. 29, 2012 - Swedish Medical Center announced today that the Ben and Catherine Ivy Center for Advanced Brain Tumor Treatment (Ivy Center) will receive an additional $2.5 million grant from the Ben & Catherine Ivy Foundation (Ivy Foundation). The grant, the second received from the Ivy Foundation in three years, will be used to identify new drugs with potential for clinical use in brain cancer treatment.
Swedish Foundation Raises $100 Million to Help Meet Increasing Demand for Regional Health-Care Services
SEATTLE, Oct. 26, 2012 – Swedish Medical Center's seven-year fund-raising initiative, called The Campaign for Swedish, has raised $103 million, exceeding its initial $100 million fund-raising goal in approximately five-and-a-half years. The Campaign, launched to help improve patient care and treatment options throughout the Swedish system, is the largest fund-raising effort undertaken by the private, non-profit health system to date.
Information from Swedish on Multistate Fungal Meningitis Outbreak among Patients who Received Contaminated Steroid Injections
SEATTLE, Oct. 23, 2012 – The U.S. Food and Drug Administration (FDA) is investigating a multistate outbreak of fungal meningitis and joint infections. It appears the outbreak is due to the contamination of an injectable steroid medication called methylprednisolone acetate produced by the New England Compounding Center (NECC). Swedish has never carried the methylprednisolone acetate product produced by NECC.